Vera Therapeutics, Inc. - COMMON STOCK (VERA) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2021 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
VERA on Nasdaq
Shares outstanding
70,934,909
Price per share
$45.11
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
74,007,882
Total reported value
$3,747,916,963
% of total 13F portfolios
0.01%
Share change
+8,795,526
Value change
+$513,375,866
Number of holders
211
Price from insider filings
$45.11
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Vera Therapeutics, Inc. - COMMON STOCK (VERA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Avoro Capital Advisors LLC 8.9% $134,640,000 5,610,000 Avoro Capital Advisors LLC 31 Dec 2024
PRICE T ROWE ASSOCIATES INC /MD/ 7.7% +33% $276,595,072 +$90,918,550 5,461,988 +49% T. Rowe Price Associates, Inc. 31 Dec 2025
VANGUARD GROUP INC 5% $180,805,107 3,570,401 The Vanguard Group 31 Dec 2025
Kynam Capital Management, LP 5.4% $83,444,698 3,426,887 Kynam Capital Management, LP 30 Jun 2025
Flynn James E 5.2% $75,299,151 3,348,117 Deerfield Mgmt, L.P. 06 Jun 2025
FMR LLC 4.1% $146,139,596 2,885,853 FMR LLC 31 Dec 2025

As of 31 Dec 2025, 211 institutional investors reported holding 74,007,882 shares of Vera Therapeutics, Inc. - COMMON STOCK (VERA). This represents 104% of the company’s total 70,934,909 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Vera Therapeutics, Inc. - COMMON STOCK (VERA) together control 82% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Avoro Capital Advisors LLC 8.3% 5,888,888 -5.2% 2.9% $298,213,288
PRICE T ROWE ASSOCIATES INC /MD/ 7.7% 5,461,976 +49% 0.03% $276,595,000
BlackRock, Inc. 6.8% 4,825,519 +14% 0% $244,364,280
DEERFIELD MANAGEMENT COMPANY, L.P. 5.7% 4,059,695 +11% 2.6% $205,582,955
VANGUARD GROUP INC 5% 3,570,401 +12% 0% $180,805,107
Kynam Capital Management, LP 4.8% 3,433,051 -15% 11% $173,849,703
Eversept Partners, LP 4.3% 3,072,304 +9.4% 8.7% $155,581,475
FMR LLC 4.1% 2,885,853 +1.5% 0.01% $146,139,597
Deep Track Capital, LP 4% 2,821,135 3.3% $142,862,276
Sofinnova Investments, Inc. 3.9% 2,793,987 0% 6.1% $141,487,502
STATE STREET CORP 3.8% 2,676,600 +15% 0% $135,543,024
Integral Health Asset Management, LLC 2.5% 1,800,000 +5.9% 4.6% $91,152,000
Point72 Asset Management, L.P. 2.5% 1,738,385 +37% 0.14% $88,031,816
Bellevue Group AG 2.4% 1,698,152 1.6% $85,994,417
GEODE CAPITAL MANAGEMENT, LLC 2% 1,444,925 +9.3% 0% $73,185,024
Pictet Asset Management Holding SA 2% 1,392,421 -3.2% 0.07% $70,512,199
Holocene Advisors, LP 1.8% 1,307,393 0.14% $66,206,382
ALLIANCEBERNSTEIN L.P. 1.7% 1,218,657 +2217% 0.02% $61,712,790
GOLDMAN SACHS GROUP INC 1.6% 1,120,780 +48% 0.01% $56,756,299
Woodline Partners LP 1.4% 1,000,279 +36% 0.2% $50,654,129
First Light Asset Management, LLC 1.2% 869,676 +72% 3.4% $44,040,393
Tri Locum Partners LP 1.1% 805,689 -32% 5.3% $40,800,091
BRAIDWELL LP 1.1% 784,742 +66% 1.3% $39,739,335
CITADEL ADVISORS LLC 1.1% 777,488 -52% 0.03% $39,371,992
AMERICAN CENTURY COMPANIES INC 1% 732,699 +3.4% 0.02% $37,103,945

Institutional Holders of Vera Therapeutics, Inc. - COMMON STOCK (VERA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 74,007,882 $3,747,916,963 +$513,375,866 $50.64 211
2025 Q3 65,067,827 $1,890,768,857 +$37,111,876 $29.06 173
2025 Q2 63,893,006 $1,505,324,602 +$17,298,219 $23.56 171
2025 Q1 62,915,975 $1,512,522,250 -$90,036,678 $24.02 176
2024 Q4 62,912,622 $2,660,465,176 +$389,856,746 $42.29 177
2024 Q3 53,519,938 $2,365,061,400 -$1,769,076 $44.20 172
2024 Q2 52,988,211 $1,917,110,562 +$57,678,654 $36.18 169
2024 Q1 51,298,718 $2,212,007,022 +$474,171,827 $43.12 157
2023 Q4 41,345,437 $635,880,813 +$44,778,975 $15.38 93
2023 Q3 39,258,779 $538,195,352 +$9,620,413 $13.71 84
2023 Q2 38,127,621 $611,912,465 +$42,587,635 $16.05 76
2023 Q1 37,354,429 $289,749,836 +$137,641,985 $7.76 69
2022 Q4 21,331,464 $412,748,829 -$7,253,468 $19.35 57
2022 Q3 21,539,667 $459,015,997 +$19,117,341 $21.31 55
2022 Q2 20,391,008 $277,615,038 +$7,846,841 $13.61 49
2022 Q1 19,483,745 $457,319,068 +$130,146,246 $23.49 49
2021 Q4 14,054,730 $374,899,000 +$10,499,638 $26.72 37
2021 Q3 14,710,587 $252,433,000 +$4,174,540 $17.35 30
2021 Q2 14,513,290 $186,104,000 +$186,104,000 $13.25 21